These data provide evidences suggesting that C504244 represses Wnt signaling likely through inhibiting β-catenin/TCF4 interaction, thereby impairing the transcription of key oncogenic targets critical for HCC progression. Here, TCF4 is linked to hepatocellular carcinoma.